These results are consistent with previous studies that reported TMPRSS1 overexpression in various cancers, especially in prostate cancer [10–14], as well as TMPRSS3 overexpression in pancreatic and ovarian cancers [16, 17]. Here, TMPRSS3 is linked to ovarian cancer.